Institutional Ownership Day One Biopharmaceuticals, Inc. (DAWN)
This table provides information about the institutional ownership of Day One Biopharmaceuticals, Inc. (DAWN). We have compiled data on the 178 institutions that hold shares in the stock, with a total of 70.5 Million shares, which have been reported (via 13F filing form) to have a value of $620 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Atlas Venture Life Science Advisors, LLC
|
Nov 13, 2025 Q3 2025 |
6,430,257
shares
|
$56.6 Million
10.23% of portfolio
|
Q1 2024
Reduced 15.48%
|
|
|
Vanguard Group Inc
Valley Forge, PA |
Nov 07, 2025 Q3 2025 |
6,181,329
shares
|
$54.4 Million
0.0% of portfolio
|
Q3 2025
Added 0.08%
|
|
|
Deerfield Management Company, L.P. (Series C)
New York, NY |
Nov 14, 2025 Q3 2025 |
4,705,413
shares
|
$41.4 Million
0.62% of portfolio
|
Q3 2025
Added 26.38%
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
4,533,442
shares
|
$39.9 Million
0.0% of portfolio
|
Q2 2024
Reduced 9.9%
|
|
|
Franklin Resources Inc
San Mateo, CA |
Nov 13, 2025 Q3 2025 |
3,477,026
shares
|
$30.6 Million
0.01% of portfolio
|
Q3 2025
Reduced 15.15%
|
|
|
Rubric Capital Management LP
New York, NY |
Nov 14, 2025 Q3 2025 |
3,377,071
shares
|
$29.7 Million
0.39% of portfolio
|
Q3 2025
New holding
|
|
|
State Street Corp
Boston, MA |
Nov 14, 2025 Q3 2025 |
3,240,444
shares
|
$28.5 Million
0.0% of portfolio
|
Q3 2025
Added 20.48%
|
|
|
Vestal Point Capital, LP
New York, NY |
Nov 14, 2025 Q3 2025 |
2,675,000
shares
|
$23.5 Million
0.85% of portfolio
|
Q3 2025
Reduced 10.83%
|
|
|
Pictet Asset Management Holding Sa
Carouge, V8 |
Nov 18, 2025 Q3 2025 |
2,373,133
shares
|
$20.9 Million
0.02% of portfolio
|
Q3 2025
Reduced 36.25%
|
|
|
Alyeska Investment Group, L.P.
Chicago, IL |
Nov 14, 2025 Q3 2025 |
2,212,187
shares
|
$19.5 Million
0.05% of portfolio
|
Q3 2025
Reduced 26.56%
|
|
|
Braidwell LP
Stamford, CT |
Nov 14, 2025 Q3 2025 |
2,181,598
shares
|
$19.2 Million
0.89% of portfolio
|
Q2 2025
Reduced 38.32%
|
|
|
Geode Capital Management, LLC
Boston, MA |
Nov 12, 2025 Q3 2025 |
1,761,264
shares
|
$15.5 Million
0.0% of portfolio
|
Q3 2025
Added 2.85%
|
|
|
Aigh Capital Management LLC
Baltimore, MD |
Oct 31, 2025 Q3 2025 |
1,520,492
shares
|
$13.4 Million
1.77% of portfolio
|
Q3 2025
New holding
|
|
|
Mak Capital One LLC
New York, NY |
Nov 14, 2025 Q3 2025 |
1,448,461
shares
|
$12.7 Million
1.57% of portfolio
|
Q3 2025
New holding
|
|
|
Balyasny Asset Management LLC
Chicago, IL |
Nov 14, 2025 Q3 2025 |
1,384,047
shares
|
$12.2 Million
0.01% of portfolio
|
Q3 2025
New holding
|
|
|
Goldman Sachs Group Inc
New York, NY |
Nov 14, 2025 Q3 2025 |
1,371,437
shares
|
$12.1 Million
0.0% of portfolio
|
Q3 2025
Reduced 18.91%
|
|
|
Hudson Bay Capital Management LP
Greenwich, CT |
Nov 13, 2025 Q3 2025 |
1,320,000
shares
|
$11.6 Million
0.04% of portfolio
|
Q3 2025
Added 1.8%
|
|
|
Algert Global LLC
San Francisco, CA |
Nov 14, 2025 Q3 2025 |
1,317,042
shares
|
$11.6 Million
0.16% of portfolio
|
Q3 2025
Added 45.36%
|
|
|
Morgan Stanley
New York, NY |
Nov 14, 2025 Q3 2025 |
1,304,029
shares
|
$11.5 Million
0.0% of portfolio
|
Q3 2025
Reduced 3.63%
|
|
|
Dimensional Fund Advisors LP
Austin, TX |
Nov 12, 2025 Q3 2025 |
1,223,284
shares
|
$10.8 Million
0.0% of portfolio
|
Q3 2025
Reduced 13.64%
|
|
|
Bank Of America Corp
Charlotte, NC |
Nov 14, 2025 Q3 2025 |
1,191,851
shares
|
$10.5 Million
0.0% of portfolio
|
Q3 2025
Added 23.45%
|
|
|
Qube Research & Technologies LTD
London, X0 |
Nov 14, 2025 Q3 2025 |
1,167,669
shares
|
$10.3 Million
0.01% of portfolio
|
Q3 2025
Added 23.67%
|
|
|
Dafna Capital Management LLC
Los Angeles, CA |
Nov 14, 2025 Q3 2025 |
999,163
shares
|
$8.79 Million
1.91% of portfolio
|
Q3 2025
Added 13.65%
|
|
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
Nov 13, 2025 Q3 2025 |
905,476
shares
|
$7.97 Million
0.01% of portfolio
|
Q3 2025
Reduced 9.5%
|
|
|
Israel Englander
Millennium Management LLC | New York, Ny
|
Nov 14, 2025 Q3 2025 |
693,320
shares
|
$6.1 Million
0.0% of portfolio
|
Q3 2025
Reduced 42.6%
|
|